Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents-Reference-Cited by-同舟云学术

Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents

Published:2020-02 Issue: Volume:187 Page:111962
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Dinavahi Saketh S.,Gowda Raghavendra,Bazewicz Christopher G.^ORCID,Battu Madhu Babu^ORCID,Lin Jyh Ming,Chitren Robert J.,Pandey Manoj K.,Amin Shantu,Robertson Gavin P.^ORCID,Gowda Krishne^ORCID

Funder

Penn State

Melanoma Research Alliance

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference62 articles.

1. Update on the aldehyde dehydrogenase gene (ALDH) superfamily;Jackson;Hum. Genom.,2011

2. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance;Januchowski;Biomed. Pharmacother.,2013

3. Role of aldehyde dehydrogenases in physiopathological processes;Rodriguez-Zavala;Chem. Res. Toxicol.,2019

4. Protein oxidation products as biomarkers;Grune;Free Radic. Biol. Med.,2014

5. 4-Hydroxynonenal in the pathogenesis and progression of human diseases;Shoeb;Curr. Med. Chem.,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Dynamic Interplay between Cancer Stem Cells and the Tumor Microenvironment in Melanoma: Implications for Novel Therapeutic Strategies;Cancers;2024-08-16

2. Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor;Molecules;2024-06-29

3. Pharmacological agents targeting drug-tolerant persister cells in cancer;Pharmacological Research;2024-05

4. Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases;Current Medicinal Chemistry;2024-03

5. Research progress on lung cancer stem cells in epidermal growth factor receptor–tyrosine kinase inhibitor targeted therapy resistance in lung adenocarcinoma;Oncology and Translational Medicine;2024-02